By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's experimental pancreatic cancer pill doubled survival ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study from the American Cancer Society is shedding light on cancer mortality rates among young people — and the one type of ...

A targeted treatment designed to trigger the death of cancer cells has shown significant promise for patients with advanced bowel cancer when combined with chemotherapy, an early trial has revealed.

A 41-year-old died of gastric cancer in 11 weeks. His widow shares what no one tells you about life after losing a spouse to ...

"After spending twelve years in the medical field caring for others, I find myself in the difficult position of needing help myself,” Christy Schroeder wrote Sam Gillette is a Staff Writer on the ...

Prostate cancer is the most common cancer in the UK but unlike breast, bowel and lung cancer, there is currently no national ...

ROCKFORD, Ill. (WIFR/Gray News) - An Illinois grandmother who cut life insurance coverage to save money is sharing her dying wish, pleading for enough support to make it to her final resting place ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...